There is an "extremely small risk" of people suffering blood clots after having the AstraZeneca jab and the benefits outweigh the risk for most people, regulators have said.
Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said: "Our position remains that the benefits of the Covid-19 vaccine AstraZeneca against Covid-19, with its associated risk of hospitalisation and death, continues to outweigh the risks for the vast majority of people.
"The balance of benefits and risks is very favourable for older people but is more finely balanced for younger people and we advise that this evolving evidence should be taken into account when considering the use of the vaccine, as JVCI has done."
Read the latest cornavirus headlines: [ Ссылка ]
#oxfordastrazeneca #vaccine #covid19 #MHRA
Subscribe to The Telegraph on YouTube ► [ Ссылка ]
Get the latest headlines: [ Ссылка ]
Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK's best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture.
